The VLDL apoB-100 pool size was also significantly decreased by sitagliptin therapy ( -9.3 % , p = 0.03 ) , mainly because of a reduction in the hepatic secretion of these lipoproteins , although this difference did not reach statistical significance ( -9.2 % , p = 0.06 ) .